In the ovalbumin-induced rat asthma model, FXR reduces airway inflammation by preventing inflammatory cell infiltration and inhibiting IL-4, IL-5, and IL-13 secretion, likely through antagonizing NFκB signaling and its target genes (Shaik et al., 2015). Here, IL13 is linked to asthma.